Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-08
2005-03-08
Low, Christopher S. F. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S388000
Reexamination Certificate
active
06864275
ABSTRACT:
Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
REFERENCES:
patent: 3010968 (1961-11-01), Loux
patent: 3370957 (1968-02-01), Wagner et al.
patent: 3499761 (1970-03-01), Dersch
patent: 3541213 (1970-11-01), Klopping
patent: 3574845 (1971-04-01), Actor et al.
patent: 3669969 (1972-06-01), Lunn
patent: 3738995 (1973-06-01), Adams et al.
patent: 3881014 (1975-04-01), Regel et al.
patent: 3956262 (1976-05-01), Heyes et al.
patent: 4046906 (1977-09-01), Frensch et al.
patent: 4731366 (1988-03-01), Munro et al.
patent: 4814329 (1989-03-01), Harsanyi et al.
patent: 5098923 (1992-03-01), Karjalainen et al.
patent: 5114951 (1992-05-01), King
patent: 5149527 (1992-09-01), Weisenthal
patent: 5290801 (1994-03-01), Higley et al.
patent: 5310748 (1994-05-01), Wilde et al.
patent: 5329012 (1994-07-01), Anderson
patent: 5364875 (1994-11-01), Wilde
patent: 5434163 (1995-07-01), Edlind et al.
patent: 5629341 (1997-05-01), Camden
patent: 5656615 (1997-08-01), Camden
patent: 5665713 (1997-09-01), Camden
patent: 5665751 (1997-09-01), Camden
patent: 5767138 (1998-06-01), Camden
patent: 5770616 (1998-06-01), Camden
patent: 5840742 (1998-11-01), Camden
patent: 5854231 (1998-12-01), Camden
patent: 5872142 (1999-02-01), Camden
patent: 5880144 (1999-03-01), Camden
patent: 5900429 (1999-05-01), Camden
patent: 5902804 (1999-05-01), Camden
patent: 5908855 (1999-06-01), Camden
patent: 5929099 (1999-07-01), Camden
patent: 5932604 (1999-08-01), Camden
patent: 5932609 (1999-08-01), Camden
patent: 6025377 (2000-02-01), Camden
patent: 6077862 (2000-06-01), Camden
patent: 6420411 (2002-07-01), Camden et al.
patent: 6423735 (2002-07-01), Camden et al.
patent: 6423736 (2002-07-01), Camden et al.
patent: 667158 (1965-11-01), None
patent: 617968 (1994-10-01), None
patent: 2155888 (1973-05-01), None
patent: S42-23274 (1963-05-01), None
patent: H06-505733 (1994-06-01), None
patent: 07 277 956 (1995-10-01), None
patent: WO 9404541 (1994-03-01), None
patent: WO 9632103 (1996-10-01), None
patent: WO 9632104 (1996-10-01), None
patent: WO 9632107 (1996-10-01), None
patent: WO 9632115 (1996-10-01), None
patent: WO 9640119 (1996-12-01), None
patent: WO 9640120 (1996-12-01), None
patent: WO 9640122 (1996-12-01), None
patent: WO 9705870 (1997-02-01), None
patent: WO 9705872 (1997-02-01), None
patent: WO 9705873 (1997-02-01), None
patent: WO 9832440 (1998-07-01), None
patent: WO 9851303 (1998-11-01), None
patent: WO 9851304 (1998-11-01), None
patent: WO 9959585 (1999-11-01), None
Goodman & Gilman's, The Phamacological Basis of Therapeutics, Ninth Edition, McGraw-Hill, New York, (1996), Chapter 50, p. 1192.*
NASR et al., “Computer Assisted Structure-Anticancer Activity Correlations of Carbamates and Thiocarbamates”, Journal of Pharmaceutical Sciences, pp. 831-836, (1985), American Pharmaceutical Association.
Chemical Abstracts 65:6570h referring to BE patent, date unknown, published in the American Chemical Society.
Delatour et al., Therapie, vol. 31, No. 4., pp. 505-515, (1976), and translation thereof.
Elgebaly et al., J. Nat. Cancer Inst., vol. 74, No. 4, pp. 811-815 (1985).
Friedman, et al., Biochemica et Biophysica Acta, 544 (1978) pp. 605-614.
Lacey, et al., Biochemical Pharma, vol. 34, No. 19, pp. 3603-3605 (1985).
Chemical Abstracts 121:175012z, (1994) p 607, Katiyar, et al.
Stedman's Medical Dictionary, 24th ed., 1983, pp./ 777-778.
Aur, J. Pediatr., 78, No. 1, (1971) pp. 129-131.
Lundy et al., Cancer Treat. Rep., vol. 62, No. 11, (1978), pp. 1955-1962.
Lundy et al., Surg. Forum, vol. 27, No. 62 (1976) pp. 132-134.
Marinovich, et al., Toxicol., vol. 94, no 1-3, (1994) pp 173-85.
Lovett, Diss. Abstr. Int., (Sci), vol. 39, No. 11, (1979) pp. 5315-5316.
Brabender, et al., Cancer Research, vol. 36 (Mar., 1976) pp. 905-916.
Atassi et al., Europ., J. Cancer, vol. 11 (1975) pp. 599-607.
Brown, et al., J. Am. Chem. Soc., 83:1764-65 (1961).
Grenda, et al., J. Org. Chem. 30,259 (1965).
W. T. Thompson, Agricultural Chemicals Book IV, Fungicides, pp. 154, 121, 123 (1993-1994).
Carter, W.A. CRC Press, Selective Inhibitors of Viral Functions, pp. 277-346 (1975).
Merck Index, Eighth Edition, 1968, p. 1035.
DuPont, Material Safety Data Sheet Beniate Fungicide, Sep. 27, 1994.
Derwent Publications, AN 95-400884 and Japan Patent Abstracts, JP 07 277956 (see above).
Telcher, et al., Breast Cancer Research and Treatment, vol. 36, No. 2, pp 227-236 (1995).
Bissery, et al., Seminars in Oncology: Management of Breast Cancer: A New Therapeutic Approach, vol. 22, No. 6-S13, pp. 3-16, (1995).
Chemical Abstracts 113:112365 (1990) Ghannoum, et al.
Ram, et al., J. Med. Chem., 35, No. 3, 539-547 (1992).
Nene, et al., International Science Publisher, Fungicides In Plant Disease Control, Chapter 9, 1993.
Private Communication to Dr. Von Hoff from National Institute of Health, National Cancer Society (1995).
Chemical Abstracts 92:123231 (1979) Menzel et al.
Lacey et al., International Journal for Parasitology, vol. 18 No. 7, pp 885-936 (1988).
Merck Index, 12thed., 7943 and 9877, Merck & Co. (NJ 1996).
Chemical Abstracts 102:217569 (1985) Elgebaly et al.
Chemical Abstracts 87:161659 (1997) Lundy et al.
Lacey, et al., Biochemical Pharma., vol. 34, no 7, pp. 1073-1077 (1985).
Lassnau, et al., Chest, vol. 104, pp 119-122 (1993).
Georgopapadakov et al., Science vol. 264, pp. 371-373 (Apr. 15, 1994).
Carter et al., Chemotherapy of Cancer, 2ndEd., John Wiley & Sons, NY, NY (1981), pp. 362-365.
Lapras, M. et al. Bull. Soc. Sci. Vet. et Med. comparee, Lyon, 1975, vol. 77, No. 6, pp. 379-397 (in French)—and English translation thereof.
Chemical Abstracts 98:66765, Vergieva (1982).
Delatour, et al., “Oncology- Embryotoxic and Antimitotic Properties of Parbendazole, Mebendazole, and Cambendazole”, C.R. Acad. Sc. Paris, Series D, (1976), pp. 517-518, vol. 282, No. 5. (English translation thereof).
Lapras, et al. “Antimitotic Properties of Some Embryotoxic and Teratogenic Antihelminthics Derived from Benzimidazole”, ), Proceeding of the European Society of Toxicology, (1977), pp. 294-296. (English translation thereof .).
Calabresi and Chabner, “Chemotherapy of Neoplastic Diseases”,Goodman&Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, (1996), pp. 1225-1229; The McGraw-Hill Companies.
Agyin Joseph K.
Camden James Berger
Quada, Jr. James Clarence
Delacroix-Muirheid C.
Low Christopher S. F.
UAF Technologies and Research, LLC
LandOfFree
Compounds and methods for use thereof in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for use thereof in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for use thereof in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3449689